Structural magnetic resonance imaging (MRI) is of fundamental importance to the diagnosis
and treatment of epilepsy, particularly when surgery is being considered. Despite previous …

Imaging is pivotal in the evaluation and management of patients with seizure disorders.
Elegant structural neuroimaging with magnetic resonance imaging (MRI) may assist in …

Abstract Objective Ultra‐high‐field 7‐Tesla (7T) magnetic resonance imaging (MRI) offers
increased signal‐to‐noise and contrast‐to‐noise ratios, which may improve visualization of …

Background and Objective To test the hypothesis that a multicenter-validated computer deep
learning algorithm detects MRI-negative focal cortical dysplasia (FCD). Methods We used …

Drug‐resistant epilepsy (DRE) considerably affects patient health, cognition, and well‐
being, and disproportionally contributes to the overall burden of epilepsy. The most common …

Epilepsy is among the most common chronic neurologic disorders, with 30%‐40% of
patients having seizures despite antiepileptic drug treatment. The advent of brain imaging …

Focal cortical dysplasias type II (FCD II) are highly epileptogenic lesions frequently causing
pharmacoresistant epilepsy. Detection of these lesions on MRI is still challenging as FCDs …

Our inability to adequately treat many patients with refractory epilepsy caused by focal
cortical dysplasia (FCD), surgical inaccessibility and failures are significant clinical …

Objective: To detect automatically focal cortical dysplasia (FCD) type II in patients with
extratemporal epilepsy initially diagnosed as MRI-negative on routine inspection of 1.5 and …

Objective In the presurgical workup of magnetic resonance imaging (MRI)‐negative (MRI−
or “nonlesional”) pharmacoresistant focal epilepsy (PFE) patients, discovering a previously …